RSS2.0

CollaGenex Halts Trial on Adverse Event

Wednesday, May 2, 2007

CollaGenex Pharmaceuticals Inc., which develops skin treatments, said Wednesday it suspended enrollment in a mid-stage acne treatment study to investigate an adverse reaction to the medication.
From: biz.yahoo.com

0 comments: